Guardion Health Sciences, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Guardion Health Sciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2017 to Q2 2024.
  • Guardion Health Sciences, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$752K, a 371% decline year-over-year.
  • Guardion Health Sciences, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$1.29M, a 178% decline year-over-year.
  • Guardion Health Sciences, Inc. annual Nonoperating Income (Expense) for 2023 was $4.49M, a 79.9% increase from 2022.
  • Guardion Health Sciences, Inc. annual Nonoperating Income (Expense) for 2022 was $2.5M, a 138930% increase from 2021.
  • Guardion Health Sciences, Inc. annual Nonoperating Income (Expense) for 2021 was $1.8K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1.29M -$752K -$592K -371% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$696K -$3.19M -$5.19M -260% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $4.49M $1.51M +$2.62M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $1.88M $1.15M +$229K +25% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.65M -$160K -$5.53M -103% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $7.18M $2M +$4.68M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $2.5M -$1.1M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $916K +$916K +134282% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $5.37M +$5.37M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$2.68M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $682 -$7.49K -91.7% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $266* -$800 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q4 2020 -$19.9K -$18.5K +$776K +97.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$795K $8.18K +$35.3K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$831K $1.07K -$235K -99.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$596K -$10.7K -$214K -105% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$381K -$794K -$914K -761% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 $533K -$27.1K -$1.03M -103% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.57M $236K -$259K -52.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $1.83M $204K +$203K +24284% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $1.62M $120K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $1.01M +$1.01M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $495K +$497K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $835 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 -$2.46K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$1.92K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.